Diabetes Mellitus, Type 2: all 9,590 studies

Page 78 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.

• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy PatientsCompletedNCT01487109Phase 2
• Observational Study of Safety of NovoMix® 30 Treatment for Type 2 DiabetesCompletedNCT01486875
• Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADsCompletedNCT01486862Phase 4
• Silastic Ring Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Obese PatientsCompletedNCT01486680Not applicable
• Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2CompletedNCT01484262
• A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes MellitusCompletedNCT01483781Phase 1
• Effectiveness of Nursing Care Plans Based in Nursing Diagnoses in Metabolic Control of Type 2 Diabetes MellitusCompletedNCT01482481
• Polyphenols and Insulin ResistanceCompletedNCT01478841Not applicable
• Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal FunctionCompletedNCT01478399Phase 1
• Vitamin D and Adipose Tissue InflammationCompletedNCT01477034Not applicable
• Orthogonal Polarisation Study in Young, Elderly and Type 2 DiabeticsCompletedNCT01476384Not applicable
• Oxidative Stress Markers Evaluation Before and After Periodontal Treatment of Diabetics Type 2 PatientsStatus unknownNCT01475435Early Phase 1
• Step Monitoring to Improve ARTERial HealthCompletedNCT01475201Not applicable
• Managing Diabetes During Pregnancy in the Wireless AgeStatus unknownNCT01474525Not applicable
• Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505CompletedNCT01474161Phase 1
• A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 DiabetesCompletedNCT01474083Phase 1/2
• Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic PatientsCompletedNCT01473147Not applicable
• Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth"CompletedNCT01472666Not applicable
• Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes MellitusCompletedNCT01472614Phase 3
• Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 DiabetesCompletedNCT01472328Not applicable
• Effects of Different Early Intensive Therapies on Long-term β-cell FunctionCompletedNCT01471808Phase 4
• Protein, Amino Acids & Insulin & Glucagon Secretion in HumansSuspendedNCT01471509Not applicable
• Chinese Medicine Treatment of Obesity With Type 2 Diabetes, DyslipidemiaStatus unknownNCT01471275Not applicable
• Early Diabetes Intervention ProgramCompletedNCT01470937Phase 4
• A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult SubjectsCompletedNCT01469468Phase 1
• Metabolic Response to 3-day Fast Versus Carbohydrate-free Diet in Type 2 DiabetesCompletedNCT01469104Not applicable
• Exploratory CSII Trial on Erectile Dysfunction in T2DM PatientsCompletedNCT01468519Phase 4
• The Effect of Roux-en-Y Gastric Bypass on Mitochondrial Function in Type 2 DiabetesStatus unknownNCT01468116
• The Effect Of Glycemic Control On Malondialdehyde, Glutathione Peroxidase, Glutathione And ParaoxonaseCompletedNCT01467674
• A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 DiabetesTerminatedNCT01467414Phase 1
• Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 DiabetesCompletedNCT01467401Phase 4
• Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01467375Phase 3
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 DiabetesCompletedNCT01467323Phase 3
• Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 DiabetesCompletedNCT01465152Phase 4
• A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.CompletedNCT01464320Phase 1
• Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) FailureCompletedNCT01461577Phase 4
• Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 DiabetesStatus unknownNCT01460459Not applicable
• Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsCompletedNCT01459809Phase 3
• Cabergoline Effect on Blood Sugar in Type 2 DiabeticsStatus unknownNCT01459601Not applicable
• Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With MetforminCompletedNCT01457911Phase 3
• Educative Intervention to Improve Type 2 Diabetes Mellitus Control in CorrientesCompletedNCT01456806Not applicable
• R230C and C230C Variants of ABCA1 and Glyburide ResponseCompletedNCT01456650Phase 4
• Effects of Food Advanced Glycation Endproducts on Vascular Function in DiabetesCompletedNCT01456026Not applicable
• A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 DiabetesWithdrawnNCT01455922Phase 3
• A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 DiabetesWithdrawnNCT01455909Phase 3
• A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650CompletedNCT01455896Phase 3
• A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 DiabetesWithdrawnNCT01455883Phase 3
• A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 DiabetesCompletedNCT01455870Phase 3
• A Study to Evaluate ITCA 650 for the Treatment of Type 2 DiabetesCompletedNCT01455857Phase 3
• The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 DiabetesCompletedNCT01455441Phase 4
• Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy SubjectsCompletedNCT01454973
• Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical PracticeCompletedNCT01454024
• Diet Oil Induced Stimulation of GLP-1CompletedNCT01453842Early Phase 1
• Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II DiabetesWithdrawnNCT01453751Not applicable
• Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic GastroparesisCompletedNCT01452815Phase 2
• Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes MellitusCompletedNCT01452451Phase 2
• Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 DiabetesCompletedNCT01449773Not applicable
• The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)CompletedNCT01449019Phase 1
• Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis PatientsCompletedNCT01448174Phase 4
• Caloric Restriction and Insulin SecretionCompletedNCT01447524Not applicable
• Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep ApneaCompletedNCT01447251Not applicable
• A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic NephropathyCompletedNCT01447147Phase 2
• Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination TherapyCompletedNCT01444248Phase 4
• Blood Glucose Stability and Variability on Two DietsStatus unknownNCT01443143Not applicable
• Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes SubjectsCompletedNCT01441986Phase 2
• Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes MellitusCompletedNCT01441921Not applicable
• Strength Training and Nutrition Development for African American YouthCompletedNCT01441323Not applicable
• A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 DiabeticsCompletedNCT01441232Phase 1
• Technology Intervention for Diabetes Engagement & Self-Care (TIDES)CompletedNCT01440530Not applicable
• A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and AlbuminuriaCompletedNCT01440257Phase 2
• Changing Diabetes® World TourCompletedNCT01437072
• Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 DiabetesStatus unknownNCT01435980Phase 4
• The Effects of Bethanechol on Glucose HomeostasisCompletedNCT01434901Phase 1
• A Study To Evaluate PF-05175157 In Healthy VolunteersCompletedNCT01433380Phase 1
• Physical Activity for a Long and Healthy LifeCompletedNCT01430143Not applicable
• A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 DiabetesCompletedNCT01427699Phase 2
• iDecide.Decido: Diabetes Medication Decision Support StudyCompletedNCT01427660Not applicable
• Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes MellitusCompletedNCT01427257Phase 1
• Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With MetforminCompletedNCT01426802Phase 4
• Two Years Maintenance of Structured Group Self-management Education in Type 2 Diabetes : a Randomized Controlled TrialCompletedNCT01425866Not applicable
• Liraglutide and Heart Failure in Type 2 DiabetesCompletedNCT01425580Phase 2
• Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and SitagliptinCompletedNCT01422590Phase 1
• Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery DiseaseCompletedNCT01422421Phase 4
• Risk Prediction in Type II Diabetics With Ischemic Heart DiseaseStatus unknownNCT01422057
• The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 DiabetesCompletedNCT01420692Not applicable
• TRANSforming InTerprofessional Cardiovascular Prevention in Primary CareCompletedNCT01418716Not applicable
• Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot StudyStatus unknownNCT01417897Phase 4
• The Effect of Exercise Training Intensity in Patients With Type 2 DiabetesCompletedNCT01417845Not applicable
• Impact of Exenatide on Sleep DurationCompletedNCT01416649
• First Time in Human Study Using GSK2330672CompletedNCT01416324Phase 1
• Stem Cell Educator Therapy in Type 2 DiabetesCompletedNCT01415726Phase 1/2
• Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes MellitusCompletedNCT01414920Phase 2
• GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 DiabetesCompletedNCT01414556Early Phase 1
• Peanuts Second Meal Glycemic ResponseCompletedNCT01413126Not applicable
• Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 DiabetesStatus unknownNCT01413035Phase 1/2
• Glycemic and Satiety Response to Fiber and Glycemic Index of Meals in DiabetesStatus unknownNCT01410292Not applicable
• German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET)CompletedNCT01409330Not applicable
• A Study in Patients With Type 2 DiabetesWithdrawnNCT01408095Phase 2
• Diagnosis and Physiopathology of Insulin AllergyCompletedNCT01407640Not applicable
• A Trial to Investigate Efficacy and Usability of Published Best Practice to Control GlycaemiaCompletedNCT01407289Phase 4

← Diabetes Mellitus, Type 2 overview